Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6760)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 18, 2015 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Russo FP, Rodríguez-Castro K, Scribano L, Gottardo G, Vanin V, Farinati F. Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease. World J Hepatol 2015; 7(8): 1097-1104 [PMID: 26052398 DOI: 10.4254/wjh.v7.i8.1097] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i8/1097.htm |
| Number | Citing Articles |
| 1 |
Mingrong Ou, Weiming Zhang, Wen Zhang, Jianmin Guo, Rui Huang, Jian Wang, Jiacheng Liu, Juan Xia, Chao Wu, Yijia Zhu, Yuxin Chen. Soluble Programmed Cell Death 1 Protein Is a Promising Biomarker to Predict Severe Liver Inflammation in Chronic Hepatitis B Patients. ACS Omega 2024; 9(14): 16716 doi: 10.1021/acsomega.4c00780
|
| 2 |
Zobair M. Younossi, Maria Stepanova, Harry L.A. Janssen, Kosh Agarwal, Mindie H. Nguyen, Ed Gane, Naoky Tsai, Issah Younossi, Andrei Racila. Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported Outcomes. Clinical Gastroenterology and Hepatology 2018; 16(10): 1641 doi: 10.1016/j.cgh.2018.02.037
|
| 3 |
Diren Arda Karaoglu, Meral Uner, Cem Simsek, Ali Osmay Gure, Secil Demirkol-Canli. Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. Biology 2023; 12(2): 188 doi: 10.3390/biology12020188
|
| 4 |
Jie Fan, Xin Huang, Juan Chen, Yiling Cai, Lin Xiong, Lihong Mu, Li Zhou. Host Genetic Variants in HLA Loci Influence Risk for Hepatitis B Virus Infection in Children. Hepatitis Monthly 2016; 16(8) doi: 10.5812/hepatmon.37786
|
| 5 |
Zhanji Zhao, Jiabing Zhu, Lijian Zhou, Nan Sun, Kaile Chang, Xiaoyue Hu, Yuting Hu, Mingzhi Ren, Yan Cheng, Derong Xu, Hongbo Xin, Chunbo Zhang. Establishment of a hydrodynamic delivery system in ducks. Transgenic Research 2024; 33(1-2): 35 doi: 10.1007/s11248-024-00377-x
|
| 6 |
Wenfan Luo, Shuai Wu, Hongjie Chen, Yin Wu, Jie Peng. Thyroid dysfunction is associated with the loss of hepatitis B surface antigen in patients with chronic hepatitis B undergoing treatment with α-interferon. Journal of International Medical Research 2021; 49(6) doi: 10.1177/03000605211025139
|
| 7 |
Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim. A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Liver International 2023; 43(8): 1813 doi: 10.1111/liv.15597
|
| 8 |
Yan Li, Qun Cai, Yafei Zhang, Qinxiu Xie, Nan Xu, Xiaoping Jiang, Jun Li, Xu Li, Zhenhua Zhang. Development of algorithms based on serum markers and transient elastography for detecting significant fibrosis and cirrhosis in chronic hepatitis B patients: Significant reduction in liver biopsy. Hepatology Research 2016; 46(13): 1367 doi: 10.1111/hepr.12696
|
| 9 |
Yang Zhuo, Yalan Yang, Mingjun Zhang, Ying Xu, Zhongping Chen, Lihong Mu, Xiaojun Tang, Zhaohui Zhong, Juan Chen, Li Zhou. Single Nucleotide Polymorphisms in IFN-γSignaling Pathway Associated with Risk of Hepatitis B Virus Infection in Chinese Children. Canadian Journal of Infectious Diseases and Medical Microbiology 2020; 2020: 1 doi: 10.1155/2020/8121659
|
| 10 |
Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Soo Young Park, Seung Up Kim. Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir. Journal of Viral Hepatitis 2021; 28(1): 95 doi: 10.1111/jvh.13411
|
| 11 |
Sammy Saab, Ping-yu Chen, Clara E. Saab, Myron J. Tong. The Management of Hepatitis B in Liver Transplant Recipients. Clinics in Liver Disease 2016; 20(4): 721 doi: 10.1016/j.cld.2016.06.004
|
| 12 |
Sara BATTISTELLA, Erica N. LYNCH, Martina GAMBATO, Alberto ZANETTO, Monica PELLONE, Sarah SHALABY, Salvatore S. SCIARRONE, Alberto FERRARESE, Giacomo GERMANI, Marco SENZOLO, Patrizia BURRA, Francesco P. RUSSO. Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy. Minerva Gastroenterology 2021; 67(1) doi: 10.23736/S2724-5985.20.02791-9
|
| 13 |
Marlone Cunha-Silva, Fábio R.T. Marinho, Paulo F. Oliveira, Tirzah M. Lopes, Tiago Sevá-Pereira, Sonia L.S. Lorena, Jazon R.S. Almeida. Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors. The Brazilian Journal of Infectious Diseases 2017; 21(4): 441 doi: 10.1016/j.bjid.2017.03.019
|
| 14 |
Qiang Li, Yu Zhou, Chenlu Huang, Weixia Li, Liang Chen. A novel diagnostic algorithm to predict significant liver inflammation in chronic hepatitis B virus infection patients with detectable HBV DNA and persistently normal alanine transaminase. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33412-z
|
| 15 |
Xiaomei Wang, Xiuzhu Gao, Ruihong Wu, Xiumei Chi, Hongqin Xu, Yazhe Guan, Qinglong Jin, Junqi Niu. Serum qAnti‐HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg‐positive immune active patients. Journal of Gastroenterology and Hepatology 2022; 37(9): 1806 doi: 10.1111/jgh.15881
|
| 16 |
Jonathan E. Barsa, Andrea D. Branch, Thomas D. Schiano. A pleasant dilemma to have: to treat the HCV patient on the waiting list or to treat post‐liver transplantation?. Clinical Transplantation 2015; 29(10): 859 doi: 10.1111/ctr.12596
|